Rhumbline Advisers »

Phathom Pharmaceuticals shares owned by Rhumbline Advisers

Quarter-by-quarter ownership of Phathom Pharmaceuticals (PHAT) shares owned by Rhumbline Advisers from 13F filings

Historical chart of Rhumbline Advisers investment in Phathom Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Phathom Pharmaceuticals held by Rhumbline Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Phathom Pharmaceuticals by Rhumbline Advisers

Quarter filed Position value Share count Share price at filing
2023-12-31 $443k 49k 9.13
2023-09-30 $586k 57k 10.37
2023-06-30 $719k 50k 14.32
2023-03-31 $234k 33k 7.14
2022-12-31 $345k 31k 11.23
2022-09-30 $321k 29k 11.10
2022-06-30 $225k 27k 8.44
2022-03-31 $272k 20k 13.62
2021-12-31 $338k 17k 19.64
2021-09-30 $560k 18k 32.08
2021-06-30 $556k 16k 33.82
2021-03-31 $428k 11k 37.58
2020-12-31 $405k 12k 33.20
2020-09-30 $400k 11k 36.63
2020-06-30 $421k 13k 32.92
2020-03-31 $295k 11k 25.83
2019-12-31 $218k 7.0k 31.21